Ravinder K Wali

Summary

Affiliation: Inova Fairfax Hospital
Country: USA

Publications

  1. doi request reprint Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials
    Ravinder K Wali
    University of Maryland School of Medicine, Baltimore, MD, USA
    Circ Heart Fail 4:18-26. 2011
  2. ncbi request reprint Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation
    Cinthia B Drachenberg
    Department of Pathology, Medicine and Pediatrics, University of Maryland, School of Medicine, Baltimore, MD 21201, USA
    Transplantation 84:323-30. 2007
  3. doi request reprint Minimizing the risk of chronic allograft nephropathy
    Matthew R Weir
    Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD 21202, USA
    Transplantation 87:S14-8. 2009
  4. doi request reprint Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Ravinder K Wali
    Department of Medicine, Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Curr Opin Organ Transplant 13:614-21. 2008
  5. ncbi request reprint Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease
    Ravinder K Wali
    Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA
    J Am Coll Cardiol 45:1051-60. 2005
  6. ncbi request reprint Spontaneous cutaneous ulcers in a patient with a moderate degree of chronic kidney disease: a different spectrum of calciphylaxis
    Wassim A Hitti
    School of Medicine, University of Maryland, 1 East University Parkway, Baltimore, MD 21218, USA
    Scand J Urol Nephrol 42:181-3. 2008
  7. ncbi request reprint Cholesterol embolization syndrome induced by thrombolytic therapy
    Wassim A Hitti
    Department of Medicine, University of Maryland Medical System, Baltimore, Maryland, USA
    Am J Cardiovasc Drugs 8:27-34. 2008
  8. ncbi request reprint Chronic kidney disease: a risk factor for cardiovascular disease
    Ravinder K Wali
    Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA
    Cardiol Clin 23:343-62. 2005
  9. ncbi request reprint Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient
    Kirk M Chan-Tack
    Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Am J Med Sci 332:364-7. 2006
  10. ncbi request reprint BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression
    Ravinder K Wali
    Division of Nephrology, Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Transplantation 78:1069-73. 2004

Detail Information

Publications10

  1. doi request reprint Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials
    Ravinder K Wali
    University of Maryland School of Medicine, Baltimore, MD, USA
    Circ Heart Fail 4:18-26. 2011
    ..We assessed whether treatment of systolic HF with carvedilol is efficacious and safe in adults with CKD...
  2. ncbi request reprint Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation
    Cinthia B Drachenberg
    Department of Pathology, Medicine and Pediatrics, University of Maryland, School of Medicine, Baltimore, MD 21201, USA
    Transplantation 84:323-30. 2007
    ..Few cases of PVAN have been attributed to JCV. Systematic studies on JCV replication in KT are lacking...
  3. doi request reprint Minimizing the risk of chronic allograft nephropathy
    Matthew R Weir
    Division of Nephrology, University of Maryland School of Medicine, Baltimore, MD 21202, USA
    Transplantation 87:S14-8. 2009
    ..The avoidance of clinical inertia in pursuing subtle changes in graft function is critical. Modification in maintenance immunosuppression may benefit many patients with early evidence of graft deterioration...
  4. doi request reprint Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Ravinder K Wali
    Department of Medicine, Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Curr Opin Organ Transplant 13:614-21. 2008
    ..Protocol biopsies have demonstrated that histological lesions of CNI toxicity can develop as early as 3 months posttransplantation...
  5. ncbi request reprint Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease
    Ravinder K Wali
    Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA
    J Am Coll Cardiol 45:1051-60. 2005
    ..We examined the impact of kidney transplantation on left ventricular ejection fraction (LVEF) in end-stage renal disease (ESRD) patients with congestive heart failure (CHF)...
  6. ncbi request reprint Spontaneous cutaneous ulcers in a patient with a moderate degree of chronic kidney disease: a different spectrum of calciphylaxis
    Wassim A Hitti
    School of Medicine, University of Maryland, 1 East University Parkway, Baltimore, MD 21218, USA
    Scand J Urol Nephrol 42:181-3. 2008
    ..We conclude that calciphylaxis should be considered in the differential diagnosis of skin ulcerations in patients with any degree of CKD...
  7. ncbi request reprint Cholesterol embolization syndrome induced by thrombolytic therapy
    Wassim A Hitti
    Department of Medicine, University of Maryland Medical System, Baltimore, Maryland, USA
    Am J Cardiovasc Drugs 8:27-34. 2008
    ..Measures to reduce the likelihood of recurrence should be taken and include avoidance of anticoagulation therapy and vascular procedures. Unfortunately, therapy remains supportive and the outcome is invariably poor...
  8. ncbi request reprint Chronic kidney disease: a risk factor for cardiovascular disease
    Ravinder K Wali
    Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, 22 South Greene Street, Baltimore, MD 21201, USA
    Cardiol Clin 23:343-62. 2005
    ..3 million of these cases of ESRD will be caused by diabetes mellitus. Thus, CVD in this high-risk population presents a challenge for the nephrology and the cardiology community...
  9. ncbi request reprint Acute renal failure and nephrotic range proteinuria due to amyloidosis in an HIV-infected patient
    Kirk M Chan-Tack
    Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
    Am J Med Sci 332:364-7. 2006
    ..Clinical diagnosis, based on CD4 count, viral load, and degree of proteinuria, may not predict the pathological diagnosis in HIV-positive patients...
  10. ncbi request reprint BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression
    Ravinder K Wali
    Division of Nephrology, Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
    Transplantation 78:1069-73. 2004
    ..BK virus nephritis (BKN) in recipients of renal allografts has reemerged during the past 5 years. Despite increased incidence, therapeutic options remain limited and progression of the disease often leads to allograft failure...